Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Arcadia Biosciences, Inc. (RKDA) had Return on Tangible Equity of -57.03% for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$4.86M |
|
$-2.34M |
|
$3.10M |
|
$1.76M |
|
$7.36M |
|
$-2.50M |
|
$0.17M |
|
$-2.33M |
|
$-2.33M |
|
$-2.34M |
|
$-2.34M |
|
$-2.34M |
|
$-2.34M |
|
$-2.50M |
|
$-2.42M |
|
1.37M |
|
1.37M |
|
$-1.71 |
|
$-1.71 |
|
| Balance Sheet Financials | |
$6.36M |
|
$0.01M |
|
$0.19M |
|
$6.55M |
|
$2.06M |
|
-- |
|
$0.35M |
|
$2.41M |
|
$4.14M |
|
$4.10M |
|
$4.14M |
|
1.37M |
|
| Cash Flow Statement Financials | |
$-4.74M |
|
$0.75M |
|
$0.01M |
|
$4.24M |
|
$0.26M |
|
$-3.98M |
|
$0.23M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.09 |
|
-- |
|
-- |
|
-- |
|
-- |
|
36.23% |
|
-51.46% |
|
-51.46% |
|
-49.71% |
|
-47.98% |
|
-48.15% |
|
$-4.74M |
|
-- |
|
-- |
|
-- |
|
0.74 |
|
2.56 |
|
11.43 |
|
31.93 |
|
-56.50% |
|
|
Return on Tangible Equity |
-57.03% |
-35.73% |
|
-56.50% |
|
$3.02 |
|
$-3.46 |
|
$-3.46 |
|